Drug-eluting Peripheral Balloon

Endovascular intervention technology originated from coronary intervention technology, and then gradually expanded to the application of systemic blood vessels. Due to the anatomical and hemodynamic characteristics of peripheral vessels, the occurrence of restenosis after peripheral intervention is more and earlier than that after coronary intervention. restenosis problem.

Generally, the drug-eluting peripheral balloon catheter is coated with a layer of drug on the surface of the PTA bare balloon catheter. The drug-eluting peripheral balloon catheter is delivered to the lesion through the guide catheter and guide wire and positioned, and the fluid is pressurized to expand the balloon at the end of the catheter. The drug coating on the surface of the balloon is in close contact with the lesion blood vessel wall, so that the drug is released rapidly and It adheres to the wall of the blood vessel of the lesion and is absorbed by the blood vessel tissue of the lesion, thereby inhibiting the proliferation of smooth muscle cells, thereby smoothing the blood vessels and reducing the occurrence of restenosis.

About Cheersonic

Cheersonic is the leading developer and manufacturer of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive.

Our coating solutions are environmentally-friendly, efficient and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.

Chinese Website: Cheersonic Provides Professional Coating Solutions